Savient (SVNT) Shares Rallying as EMA Accepts Review of MAA for Krystexxa
Tweet Send to a Friend
Shares of Savient Pharma (Nasdaq: SVNT) have pushed over the $7.70 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
